CTVA — Corteva Income Statement
0.000.00%
- $41.98bn
- $41.76bn
- $16.91bn
- 90
- 35
- 94
- 86
Annual income statement for Corteva, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 14,217 | 15,655 | 17,455 | 17,226 | 16,908 |
Cost of Revenue | |||||
Gross Profit | 5,710 | 6,435 | 7,019 | 7,306 | 7,379 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 13,711 | 14,606 | 15,872 | 15,631 | 15,184 |
Operating Profit | 506 | 1,049 | 1,583 | 1,595 | 1,724 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 675 | 2,346 | 1,426 | 1,093 | 1,275 |
Provision for Income Taxes | |||||
Net Income After Taxes | 756 | 1,822 | 1,216 | 941 | 863 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 681 | 1,759 | 1,147 | 735 | 907 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 681 | 1,759 | 1,147 | 735 | 907 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.27 | 2.87 | 2.06 | 1.92 | 1.64 |
Dividends per Share |